Elevated Plasma Chromogranin A Is the First Indication of Recurrence in Radically Operated Midgut Carcinoid Tumors

Publisher： Karger

E-ISSN： 1423-0194|89|3|302-307

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.89, Iss.3, 2009-01, pp. : 302-307

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Complications of Midgut Carcinoid Tumors and Carcinoid Syndrome

By  

Neuroendocrinology, Vol. 80, Iss. 1, 2004-10 ,pp. : 28-32

Karger

Access to resources Recommend Favorite

Expression of Tyrosine Kinase Receptors in Malignant Midgut Carcinoid Tumors

By  

Neuroendocrinology, Vol. 84, Iss. 1, 2006-12 ,pp. : 42-48

Karger

Access to resources Recommend Favorite

Sexual Function in Patients with Metastatic Midgut Carcinoid Tumours

By  

Neuroendocrinology, Vol. 89, Iss. 2, 2008-11 ,pp. : 231-236

Karger

Access to resources Recommend Favorite

An Evaluation of Cyclooxygenase-2 as a Prognostic Biomarker in Mid-Gut Carcinoid Tumours

By  

Neuroendocrinology, Vol. 86, Iss. 2, 2007-08 ,pp. : 104-111

Karger

Access to resources Recommend Favorite

Chromogranin A Is a Reliable Biomarker for Gastroenteropancreatic Neuroendocrine Tumors in an Asian Population of Patients

By  

Neuroendocrinology, Vol. 95, Iss. 4, 2012-02 ,pp. : 344-350

Karger

Access to resources Recommend Favorite